bullish

uniQure NV

thoughts on AMT-130 & HD interventions broadly

100 Views22 Sep 2026 10:27
Syndicated
SUMMARY
  • SKY-515 came out with 15-month interim data recently.
  • What was said in the press release was unsurprising in light of the 12-month data shared.
  • At 12 months, participants receiving SKY-0515 demonstrated favorable outcomes across every component of the composite Unified Huntington’s Disease Rating Scale (cUHDRS): Total Functional Capacity (TFC): Mean change from baseline of +0.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • thoughts on AMT-130 & HD interventions broadly
    22 Sep 2026
x